The delayed type hypersensitivity (DTH) for benzylpenicilloyl (BPO) group was observed in the footpad swelling reaction (FSR) in mice. Mice were subcutaneously immunized with 300 pg of BPO-human serum albumin (HSA) conjugate and Freund's complete adjuvant and challenged into footpads with 25 erg of BPO-bovine gamma globulin (BGG) conjugate 2 weeks after the immunization.
penicillins contained the common reactivity for the penicilloyl moiety. The DTH for BPO was suppressed by intravenous preadministration of HSA and this suppression was sensitive to cyclophosphamide.
Penicillins and cephalosporins
are potentially capable of inducing all types of allergic reactions as defined by COOMBS and GELL1) . Type I, II and III allergy are thought to be elicited by humoral antibodies such as IgE, IgG and IgM antibodies. Type IV allergy is elicited by the cell-mediated immunity.
The properties of the IgG antibodies for penicillins and cephalosporins have been closely investigated in detail2~6). Moreover, we have studied the properties and antigenic specificities of the IgE antibodies for penicillins and cephalosporins in rats.
The difference between the antigenic specificities of IgG and IgE antibodies was described previously.? Namely, the IgG antibodies for penicillin could react with both the acyl side chain moiety and the penicilloyl moiety of penicillin, but the rat IgE antibodies for penicillin could react only with the acyl side chain moiety. However, the cell-mediated immunity for penicillins and cephalosporins has not been well-studied yet. The present studies are, therefore, designed to investigate the induction and characterization of the delayed type hypersensitivity (DTH) for penicillins in mice whose DTH has been clarified by several reports.8)
Materials and Methods

Animals
Ta : A/J, Ta : BALB/c, Ta : C3 H/He, Ta : C57BL/6 and Ta : DBA/2 mice were bred at Takeda Chemical Industries, Ltd., Osaka, Japan. Mice were routinely used at 7 9 weeks of age for the immunization.
VOL. XXXIV NO. 4 THE JOURNAL OF ANTIBIOTICS Chemicals Penicillin G(PCG), ampicillin(ABPO) and sulbenicillin(SBPO) were obtained from commercial sources of Takeda Chemical Industries, Ltd., Osaka, Japan. 6-Formamidopenicillanic acid(FPC) was synthetized in Takeda Chemical Industries, Ltd. Human serum albumin(HSA) and bovine gamma globulin(BGG) were purchased from Nutritional Biochemicals Corporation, Cleveland, Ohio, U.S.A.
Preparation of Penicilloyl-protein Conjugate One hundred mg of HSA or BGG was dissolved in 10 ml of physiological saline, and penicillin was added at ratio of 50 ' 2,000 M vs. 1 M protein. The reaction mixture was adjusted at pH 10.5 with 1 N NaOH. After 24 hours incubation at 37°C, the reaction mixture was dialysed at 4°C for 3 days continuously against 5 liters of physiological saline and then penicilloyl-protein conjugate was chromatographed on Sephadex G-25 (Pharmacia Fine Chemicals, Uppsala, Sweden) column (3 x 100 cm). The epitope densities of penicilloyl groups in penicilloyl-protein conjugates were measured by the penamaldate method° . Penicilloyl-protein conjugates used in this study were benzylpenicilloyl (BPO)3, 6, 8,15, 30-HSA, ampicilloyl (ABPO)28-HSA, sulbenicilloyl (SBPO)32-HSA, 6-formamidopenicilloyl (FPO)19-HSA, BPO4,8,18,30,51-BGG, ABPO50-BGG, SBPO38-BGG and FPO30-BGG.
Immunization Following the method of SNIPPE10), mice were subcutaneously immunized with 0.2 ml of the emulsion of 3 -3,000 ,ug of penicilloyl-HSA and Freund's complete adjuvant (FCA : Difco). Elicitation of the footpad swelling reaction (FSR) and its measurements. Mice were intradermally challenged into the left hind footpad with 0.04 ml of 0.4 N 100 pg of penicilloyl-BGG saline solution 4 N 30 days after the immunization. The same volume of saline was injected into the right hind footpad. The degree of the FSR was estimated by the method of KERKHAERT11). The thickness of both footpads was measured 3 to 72 hours after the antigen challenge, using the dial thickness gauge (Peacock). The FSR was represented as the difference between the thickness of the left and right footpad.
Measurement of Serum Antibodies for the Penicilloyl Group Penicilloyl-BGG sensitized sheep red blood cells (SRBC) were prepared by the glutaraldehydetannic acid method 12) and serum antibodies for penicilloyl group were measured by the micro-titer method.
Histological Study Hind footpads were fixed in 10 % neutral formalin 48 hours after the antigen challenge, embedded in paraffin, sectioned at 5,u thickness and stained with hematoxylin-eosin.
Lightmicroscopical observation was performed.
Transfer of the Footpad Swelling Reaction (FSR) Mice were subcutaneously immunized with 300 jig of BPO-HSA and FCA and spleen cells were obtained 13 days after the immunization. Forty pl of RPMI-1640 medium (Gibco) containing 5 x 107 spleen cells and 40 ,ug of BPO51-BGG was intradermally transferred into the left footpad and the FSR was measured 24 hours after the challenge.
Treatment of Spleen Cells by Anti-Thy-1,2 Serum Anti-Thy-1,2 serum was purchased from Olac 1976 Ltd., Bicester, England and its cytotoxic titer for thymocytes was 500,000. Spleen cells were suspended at 5 x 107 cells/ml in RPMI 1640 medium, and added 1/10 volume of 100-fold diluted anti-Thy-1,2 serum and 1/10 volume of guinea pig serum absorbed by red blood cells and spleen cells, and the cell suspension was incubated at 37°C for 45 minutes.
Desensitization of the Footpad Swelling Reaction (FSR) One mg of penicilloyl-BGG saline solutions were intravenously injected to the mice immunized with the penicilloyl-HSA and FCA 14 days before. Soon after the i.v. antigen-administration, mice were challenged with penicilloyl-BGG.
Induction of Suppression of Hapten-specific DTH and its Sensitivity for Treatment by Cyclophosphamide Suppression of hapten-specific DTH was induced by intravenous administration of 300 pg of HSA a week before the immunization of BPO-HSA and FCA. Treatment of mice by cyclophosphamide was performed by intraperitoneal administration of 150 mg/kg of cyclophosphamide 4 days after the induction of suppression of DTH.
Results
Effect of Various Factors on the Induction of Footpad Swelling Reaction (FSR)
A/J mice were subcutaneously immunized with BPO-HSA and FCA and challenged into footpads with 25 pg of BPO51-BGG on day 11 after the immunization. FSR was measured 24 hours after the antigen challenge. The optimal dose of BP020-HSA in immunization was 300 pg/mouse, and more than 15 moles of BPO groups were necessary to be bound per mole of HSA for induction of the strong FSR. C57BL/6 and C3H/He mice were high responders, A/J mice moderate, and BALB/c and DBA/2 mice were low responders. In this study A/J mice were routinely used and 300 pg of BP030-HSA was used for immunization ( Table 1) .
Effect of Various Factors on Footpad Swelling Reaction (FSR)
Mice were subcutaneously immunized with 300 pg of BP030-HSA and FCA and challenged into footpads with 0.04 ml of BPO-BGG saline solution. FSR was measured 24 hours after the challenge. This FSR was specific for the BPO group ( Table 2) .
Kinetics of Induction of Footpad Swelling Reaction (FSR) and Antibody Response FSR could be induced on day 4 and reached the maximum on day 11 ti 14 after the immunization.
Thereafter, FSR decreased gradually and was very weak on day 30 after the immunization. 2-Mercaptoethanol(2-ME) sensitive antibodies(IgM) for BPO were detected 2 weeks after the immunization and total antibodies for BPO reached the maximum 3 weeks after the immunization. 2-ME resistant antibodies (IgG) for BPO was first observed 3 weeks after the immunization and gradually increased up to 5 weeks after the immunization (Fig. 1) .
Kinetics of Footpad Swelling Reaction (FSR)
Mice were immunized with BPO-HSA and challenged with BPO-BGG on day 12 after the immunization. The thickness of footpads decreased up to 6 hours after the challenge, then rapidly increased and reached the maximum 18 24 hours after the challenge. Thereafter, the thickness of the footpad gradually decreased (Fig. 2) . (Table 3) .
Transfer of the Footpad Swelling Reaction (FSR) and its
Histological Study
Infiltration of monocytes was observed and polymorphonuclear cells were not observed in the footpads 48 hours after the antigen challenge (Fig. 3) . But in the footpads 24 hours after the antigen challenge, a few polymorphonuclear cells were observed, and such infiltration of polymorphonuclear cells was usually observed in FSR of mice.
Cross-reactivity of Penicillins in DTH
Various penicilloyl-BGG were challenged to the mice immunized with penicilloyl-HSA; BPO, ABPO and SBPO groups cross-reacted with each other and the FPO group cross-reacted even more with BPO, ABPO and SBPO groups.
When more than 100 ug of penicilloyl-BGG was intravenously injected to the mice just before the antigen challenge, FSR was almost inhibited.
Then, mice were intravenously injected with 1 mg of various penicilloyl-BGGs just before the antigen challenge corresponding to the immunized antigen. BPO-, ABPO-and SBPO-BGGs could inhibit the FSRs for BPO, ABPO and SBPO.
And BPO-, ABPO-and SBPO-BGGs could inhibit the FSR for FPO as well as FPO-BGG.
The common cross-reactivity was observed in FSR and its desensitization ( Table 4) .
Induction of Suppression of Hapten-specific DTH and its Sensitivity for Treatment by Cyclophosphamide
The FSR for BPO was suppressed by the preadministration of carrier protein (HSA). Mice were immunized with BPO-HSA and FCA and challenged with BPO-BGG 12 days after immunization.
Footpads were fixed with 10 neutral formalin 48 hours after challenge and stained with hematoxylin-eosin. Mice were i.v. administered with 300 pug of HSA on day 0, i.p. administered with 150 mgjkg of CPA on day 4 and immunized with BPO-HSA on day 7. Footpad swelling reaction was measured 14 days after immunization. a) Mean±SE of 5 mice .
bably, the ARTHUS reaction was enhanced when the circulating antibodies were produced. In our preliminary experiment we observed that the suppression of FSR was transferred to the mice immunized 2 weeks before by the antigen-primed spleen cells obtained 5 weeks after the immunization. Therefore it is felt that the DTH suppressor cells exist in the cells resulting to antibody production system. Relative to the suppression of DTH, intravenous administration of antigen was often used15~ and the induction of suppressor cells of DTH in this procedure was attempted.
The intravenous preadministration of carrier protein HSA could induce the suppressor of the hapten-specific DTH since the effect of intravenous preadministration of carrier protein disappeared by the treatment of cyclophosphamide.
